US2003021859A1PendingUtilityA1

Soy formulations and their use for promoting health

50
Priority: Jul 16, 1998Filed: Sep 30, 2002Published: Jan 30, 2003
Est. expiryJul 16, 2018(expired)· nominal 20-yr term from priority
Inventors:Aaron Tabor
A23L 11/07A61K 31/47A23L 33/105A61K 31/35A23L 33/185A61K 31/7048A23V 2002/00A23L 33/40A61K 31/352
50
PatentIndex Score
0
Cited by
0
References
0
Claims

Abstract

The present invention provides novel soy formulations comprising 3-23 milligrams of at least one isoflavone per gram of the formulation. The soy formulations may additionally comprise 0.4 to 1.2 grams of protein per gram of the formulation. In another aspect, the present invention provides novel soy formulations comprising diadzin, genistin and glycitin in a ratio of 3:1:2 to 3:4.5:1, preferably approximately 2:1:1 such that diadzin is a major isoflavone component. The present invention further provides dietary supplements and food products comprising a soy formulation of the present invention. In another aspect the present invention provides pharmacological compositions comprising a soy formulation of the present invention. The pharmacological compositions may additionally comprise a medicinal composition. Also disclosed are methods for promoting the health of an individual, preferably utilizing the soy formulations, dietary supplements, food products and/or pharmacological compositions of the present invention.

Claims

exact text as granted — not AI-modified
1 . A natural soy formulation comprising 3 to 23 milligrams of at least one isoflavone per gram of the formulation.  
     
     
         2 . The natural soy formulation of  claim 1  wherein the soy formulation comprises 5 to 15 milligrams of at least one isoflavone per gram of the formulation.  
     
     
         3 . The natural soy formulation of  claim 2  wherein the soy formulation comprises 6 to 9 milligrams of at least one isoflavone per gram of the formulation.  
     
     
         4 . The natural soy formulation of  claim 1  wherein the isoflavone comprises diadzin.  
     
     
         5 . The natural soy formulation of  claim 4  wherein the soy formulations comprises a plurality of isoflavones comprising diadzin, genistin and glycitin.  
     
     
         6 . The natural soy formulation of  claim 5  wherein the diadzin to genistin to glycitin ratio is between 3:1:2 and 3:4.5:1.  
     
     
         7 . A natural soy formulation comprising isoflavones diadzin, genistin and glycitin wherein the diadzin to genistin to glycitin ratio is between 3:1:2 and 3:4.5:1.  
     
     
         8 . The natural soy formulation of  claim 7  wherein the diadzin to genistin to glycitin ratio is approximately 2:1:1.  
     
     
         9 . The natural soy formulation of  claim 7  wherein the isoflavones comprise their glycone forms.  
     
     
         10 . The natural soy formulation of  claim 7  wherein the isoflavones comprise their aglycone forms.  
     
     
         11 . A natural soy formulation comprising: 
 3 to 23 milligrams of at least one isoflavone; and    0.4 to 1.2 grams protein;    per gram of the formulation.    
     
     
         12 . The natural soy formulation of  claim 11  wherein the soy formulation comprises 5 to 15 milligrams of at least one isoflavone per gram of the formulation.  
     
     
         13 . The natural soy formulation of  claim 12  wherein the soy formulation comprises 6 to 9 milligrams of at least one isoflavone per gram of the formulation.  
     
     
         14 . The natural soy formulation of  claim 11  wherein the soy formulation comprises 0.4 to 0.9 grams protein per gram of the formulation.  
     
     
         15 . The natural soy formulation of  claim 13  wherein the soy formulation comprises 0.4 to 0.9 grams protein per gram of the formulation.  
     
     
         16 . The natural soy formulation of  claim 11  wherein the isoflavone comprises diadzin.  
     
     
         17 . The natural soy formulation of  claim 15  wherein the isoflavone comprises diadzin.  
     
     
         18 . The natural soy formulation of  claim 15  wherein the soy formulations comprises a plurality of isoflavones comprising diadzin, genistin and glycitin.  
     
     
         19 . The natural soy formulation of  claim 18  wherein the diadzin to genistin to glycitin ratio is between 3:1:2 and 3:4.5:1.  
     
     
         20 . A natural soy formulation produced by combining a first portion of higher isoflavone concentration soy product produced from the heart of the soy bean and a second portion of lower isoflavone concentration soy product produced from the whole soy bean to achieve a soy formulation comprising 3 to 23 milligrams of at least one isoflavone per gram of the formulation.  
     
     
         21 . The natural soy formulation of  claim 20  wherein the soy formulation further comprises 0.4 to 1.2 grams protein per gram of the formulation.  
     
     
         22 . The natural soy formulation of  claim 20  wherein the soy formulation comprises 6 to 9 milligrams of at least one isoflavone per gram of the formulation.  
     
     
         23 . The natural soy formulation of  claim 21  wherein the soy formulation comprises 6 to 9 milligrams of at least one isoflavone per gram of the formulation.  
     
     
         24 . The natural soy formulation of  claim 23  wherein the soy formulation comprises 0.4 to 0.9 grams protein per gram of the formulation.  
     
     
         25 . A dietary supplement comprising the soy formulation of  claim 1  wherein the amount of the soy formulation in the dietary supplement is sufficient to provide greater than 60 milligrams of at least one isoflavone per serving.  
     
     
         26 . A dietary supplement comprising the soy formulation of  claim 7  wherein the amount of the soy formulation in the dietary supplement is sufficient to provide greater than 60 milligrams of at least one isoflavone per serving.  
     
     
         27 . A dietary supplement comprising the soy formulation of  claim 11  wherein the amount of the soy formulation in the dietary supplement is sufficient to provide greater than 60 milligrams of at least one isoflavone per serving.  
     
     
         28 . A food product comprising the soy formulation of  claim 1  wherein the amount of the soy formulation in the food product is sufficient to provide greater than 60 milligrams of at least one isoflavone per serving.  
     
     
         29 . A food product comprising the soy formulation of  claim 7  wherein the amount of the soy formulation in the food product is sufficient to provide greater than 60 milligrams of at least one isoflavone per serving.  
     
     
         30 . A food product comprising the soy formulation of  claim 11  wherein the amount of the soy formulation in the food product is sufficient to provide greater than 60 milligrams of at least one isoflavone per serving.  
     
     
         31 . A pharmcological composition comprising the soy formulation of  claim 1  wherein the amount of the soy formulation in the pharmacological composition is sufficient to provide greater than 60 milligrams of at least one isoflavone per dose.  
     
     
         32 . The pharmacological composition of  claim 31  further comprising a medicinal composition in an amount per dose sufficient to produce a desired therapeutic effect.  
     
     
         33 . The pharmacological composition of  claim 32  wherein the medicinal composition comprises: Premarin; Fosamax; Raloxifene; Tamoxifen; or an SERM.  
     
     
         34 . A pharmcological composition comprising the soy formulation of  claim 7  wherein the amount of the soy formulation in the pharmacological composition is sufficient to provide greater than 60 milligrams of at least one isoflavone per dose.  
     
     
         35 . The pharmacological composition of  claim 34  further comprising a medicinal composition in an amount per dose sufficient to produce a desired therapeutic effect.  
     
     
         36 . The pharmacological composition of  claim 35  wherein the medicinal composition comprises: Premarin; Fosamax; Raloxifene; Tamoxifen; or an SERM.  
     
     
         37 . A pharmcological composition comprising the soy formulation of  claim 11  wherein the amount of the soy formulation in the pharmacological composition is sufficient to provide greater than 60 milligrams of at least one isoflavone per dose.  
     
     
         38 . The pharmacological composition of  claim 37  further comprising a medicinal composition in an amount per dose sufficient to produce a desired therapeutic effect.  
     
     
         39 . The pharmacological composition of  claim 38  wherein the medicinal composition comprises: Premarin; Fosamax; Raloxifene; Tamoxifen; or an SERM.  
     
     
         40 . A method for promoting the health of an individual comprising having the individual ingest greater than 60 milligrams of at least one isoflavone per day.  
     
     
         41 . The method of  claim 40  wherein the method comprises having the individual ingest 120 to 200 milligrams of at least one isoflavone per day.  
     
     
         42 . The method of  claim 40  wherein the step of having the individual ingest greater than 60 milligrams of at least one isoflavone per day comprises having the individual ingest a soy formulation of  claim 1 .  
     
     
         43 . The method of  claim 40  wherein the step of having the individual ingest greater than 60 milligrams of at least one isoflavone per day comprises having the individual ingest a soy formulation of  claim 7 .  
     
     
         44 . The method of  claim 40  wherein the step of having the individual ingest greater than 60 milligrams of at least one isoflavone per day comprises having the individual ingest a soy formulation of  claim 11 .  
     
     
         45 . The method of  claim 40  wherein the step of having the individual ingest greater than 60 milligrams of at least one isoflavone per day comprises having the individual ingest a pharmacological composition of  claim 32 .  
     
     
         46 . The method of  claim 40  wherein the step of having the individual ingest greater than 60 milligrams of at least one isoflavone per day comprises having the individual ingest a pharmacological composition of  claim 35 .  
     
     
         47 . The method of  claim 40  wherein the step of having the individual ingest greater than 60 milligrams of at least one isoflavone per day comprises having the individual ingest a pharmacological composition of  claim 38 .  
     
     
         49 . The method of  claim 40  wherein the promoting of the health of the individual comprises reducing menopausal like symptoms.  
     
     
         50 . The method of  claim 49  wherein the menopausal like symptoms comprise hot flashes, vaginal itching, vaginal dryness, irritability, insomnia, night sweats, headaches and/or mood swings.  
     
     
         51 . The method of  claim 40  wherein the promoting of the health of the individual comprises soothing menstrual problems.  
     
     
         52 . The method of  claim 40  wherein the promoting of the health of the individual comprises decreasing fatigue.  
     
     
         53 . The method of  claim 40  wherein the promoting of the health of the individual comprises reducing the effects of Alzheimer's type dementia.  
     
     
         54 . The method of  claim 40  wherein the promoting of the health of the individual comprises reducing the risk of breast cancer.

Join the waitlist — get patent alerts

Track US2003021859A1 — get alerts on status changes and closely related new filings.

We store only your email — no account needed. See our privacy policy.